Henrique Oliveira obtained his bachelor’s degree in Biochemistry in 2020 from the University of Aveiro, being his final project focused on the use of Brewer’s Spent Yeast Microcapsules as Oral Delivery Systems. He is currently a Biochemistry master’s student at the same institution, specializing in the Clinical branch, integrating the Compass group to develop his master’s thesis, focusing on the development of a nanovaccine to boost cancer immunogenicity.